Glucose-regulated protein 78 (GRP78) as a potential novel biomarker and therapeutic target in multiple myeloma
- PMID: 32990063
- DOI: 10.1080/17474086.2020.1830372
Glucose-regulated protein 78 (GRP78) as a potential novel biomarker and therapeutic target in multiple myeloma
Abstract
Introduction: Glucose-regulated protein 78 (GRP78) is a stress-inducible molecular chaperone expressed within the endoplasmic reticulum where it acts as a master regulator of the unfolded protein response (UPR) pathway. At times of ER stress, activation of the UPR, a multimolecular pathway, limits proteotoxicity induced by misfolded proteins. In malignancies, including multiple myeloma which is characterized by an accumulation of misfolded immunoglobulins, GRP78 expression is increased, with notable translocation of GRP78 to the cell surface. Studies suggest cell-surface GRP78 (csGRP78) to be of prognostic significance with emerging evidence that it interacts with a myriad of co-ligands to activate signaling pathways promoting cell proliferation and survival or apoptosis.
Areas covered: This review focuses on the role of ER and csGRP78 in physiology and oncogenesis in multiple myeloma, addressing factors that shift the balance in GRP78 signaling from survival to apoptosis. The role of GRP78 as a potential prognostic biomarker is explored and current therapeutics in development aimed at targeting csGRP78 are addressed. We conducted a PubMed literature search using the keywords 'GRP78,' 'multiple myeloma' reviewing studies prior to 2020.
Expert opinion: Cell-surface GRP78 expression is a potential novel prognostic biomarker in myeloma and targeting of csGRP78 is promising and requires further investigation.
Keywords: Biomarker; ER stress; glucose-regulated protein 78 (GRP78); multiple myeloma; therapeutic target.
Similar articles
-
Glucose-regulated protein (GRP78) is an important cell surface receptor for viral invasion, cancers, and neurological disorders.IUBMB Life. 2021 Jun;73(6):843-854. doi: 10.1002/iub.2502. Epub 2021 May 15. IUBMB Life. 2021. PMID: 33960608 Review.
-
GRP78: A cell's response to stress.Life Sci. 2019 Jun 1;226:156-163. doi: 10.1016/j.lfs.2019.04.022. Epub 2019 Apr 9. Life Sci. 2019. PMID: 30978349 Free PMC article. Review.
-
Pharmacologic screens reveal metformin that suppresses GRP78-dependent autophagy to enhance the anti-myeloma effect of bortezomib.Leukemia. 2015 Nov;29(11):2184-91. doi: 10.1038/leu.2015.157. Epub 2015 Jun 25. Leukemia. 2015. PMID: 26108695 Free PMC article.
-
Molecular chaperone GRP78 enhances aggresome delivery to autophagosomes to promote drug resistance in multiple myeloma.Oncotarget. 2015 Feb 20;6(5):3098-110. doi: 10.18632/oncotarget.3075. Oncotarget. 2015. PMID: 25605012 Free PMC article.
-
Protein kinase CK2 protects multiple myeloma cells from ER stress-induced apoptosis and from the cytotoxic effect of HSP90 inhibition through regulation of the unfolded protein response.Clin Cancer Res. 2012 Apr 1;18(7):1888-900. doi: 10.1158/1078-0432.CCR-11-1789. Epub 2012 Feb 20. Clin Cancer Res. 2012. PMID: 22351691
Cited by
-
Single-cell transcriptomic atlas throughout anti-BCMA CAR-T therapy in patients with multiple myeloma.Front Immunol. 2023 Nov 14;14:1278749. doi: 10.3389/fimmu.2023.1278749. eCollection 2023. Front Immunol. 2023. PMID: 38035111 Free PMC article.
-
Pharmacologic targeting of the p62 ZZ domain enhances both anti-tumor and bone-anabolic effects of bortezomib in multiple myeloma.Haematologica. 2024 May 1;109(5):1501-1513. doi: 10.3324/haematol.2023.283787. Haematologica. 2024. PMID: 37981834 Free PMC article.
-
Unveiling the dark side of glucose-regulated protein 78 (GRP78) in cancers and other human pathology: a systematic review.Mol Med. 2023 Aug 21;29(1):112. doi: 10.1186/s10020-023-00706-6. Mol Med. 2023. PMID: 37605113 Free PMC article. Review.
-
Is It Still Possible to Think about HSP70 as a Therapeutic Target in Onco-Hematological Diseases?Biomolecules. 2023 Mar 28;13(4):604. doi: 10.3390/biom13040604. Biomolecules. 2023. PMID: 37189352 Free PMC article. Review.
-
The synthetic oleanane triterpenoid CDDO-2P-Im binds GRP78/BiP to induce unfolded protein response-mediated apoptosis in myeloma.Mol Oncol. 2023 Dec;17(12):2526-2545. doi: 10.1002/1878-0261.13447. Epub 2023 Jun 13. Mol Oncol. 2023. PMID: 37149844 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous